National Health Investors Q2 earnings tops consensus, lifts 2022 guidance (NYSE:NHI)
National Health Investors (NHI) increased its guidance for 2022 normalized FFO per share to $4.48-$4.53, slightly under the $4.54 consensus estimate, from its previous range…
National Health Investors Q2 earnings tops consensus, lifts 2022 guidance (NYSE:NHI)
National Health Investors (NHI) increased its guidance for 2022 normalized FFO per share to $4.48-$4.53, slightly under the $4.54 consensus estimate, from its previous range…